Ozempic (Semaglutide) for the treatment of obesity: advantages and disadvantages from an integrative analysis. RSD [Internet]. 2022 Sep. 4 [cited 2025 Dec. 15];11(11):e587111133963 . Available from: https://www.rsdjournal.org/rsd/article/view/33963